Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule.

Breast Cancer Research : BCR
Hazem GhebehSaid Dermime

Abstract

B7-H1 (PD-L1, CD274) is a T cell inhibitory molecule expressed in many types of cancer, leading to immune escape of tumor cells. Indeed, in previous reports we have shown an association of B7-H1 expression with high-risk breast cancer patients. In the current study, we used immunohistochemistry, immunofluorescence and Western blot techniques to investigate the effect of neoadjuvant chemotherapy on the expression of B7-H1 in breast cancer cells. Among tested chemotherapeutic agents, doxorubicin was the most effective in downregulating cell surface expression of B7-H1 in vitro. These results were validated in vivo in a xenograft mouse model, as well as in murine heart tissue known to constitutively express B7-H1. The doxorubicin-dependent cell surface downregulation of B7-H1 was accompanied by an upregulation of B7-H1 in the nucleus. This re-distribution of B7-H1 was concurrent with a similar translocation of phosphorylated AKT to the nucleus. Inhibition of the PI3K/AKT pathway abrogated the doxorubicin-mediated nuclear up-regulation of B7-H1, suggesting an involvement of PI3K/AKT pathway in the nuclear up-regulation of B7-H1. Interestingly, siRNA knock down of B7-H1 lead to an increase in spontaneous apoptosis, as well as doxoru...Continue Reading

References

Sep 25, 1991·JAMA : the Journal of the American Medical Association·L J SteinherzM L Murphy
Jan 25, 1988·Biochimica Et Biophysica Acta·D H Bell
Oct 1, 1981·Cancer Research·J S Haskill
Dec 2, 1999·Nature Medicine·A K Abbas, A H Sharpe
Jan 11, 2000·Molecular and Cellular Biology·W WangM Gorospe
Sep 22, 2000·The Biochemical Journal·S P DaviesP Cohen
Aug 15, 2002·British Medical Bulletin·Said DermimePeter L Stern
Dec 20, 2002·Current Opinion in Oncology·Yaddanapudi Ravindranath
Mar 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nicole Selenko-GebauerJohannes Stöckl
Jul 9, 2004·Biochimica Et Biophysica Acta·Said DermimePeter L Stern
Feb 19, 2005·Science·D D SarbassovDavid M Sabatini
Dec 21, 2005·The Journal of Experimental Medicine·Noelia CasaresGuido Kroemer
Dec 28, 2005·Biochemical and Biophysical Research Communications·Yusuke FujiwaraMichiaki Kohno
Dec 13, 2006·Nucleic Acids Research·Mai A Al-MohannaAbdelilah Aboussekhra
Dec 26, 2006·Nature Medicine·Michel ObeidGuido Kroemer
Apr 7, 2007·International Journal of Cancer. Journal International Du Cancer·Hazem GhebehSaid Dermime
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xingxing Zang, James P Allison
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kunihiro TsukasakiUNKNOWN Japan Clinical Oncology Group Study JCOG9801
Nov 9, 2007·The New England Journal of Medicine·Christophe FerméUNKNOWN EORTC-GELA H8 Trial
Jan 29, 2008·Blood·Takeshi AzumaLieping Chen
Mar 21, 2008·Trends in Molecular Medicine·Lionel ApetohLaurence Zitvogel
Oct 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yeong Seok KimDae Young Hur
Mar 18, 2009·The Journal of Cell Biology·Thoru Pederson, Robert Y L Tsai

❮ Previous
Next ❯

Citations

Feb 8, 2013·Cancer Immunology, Immunotherapy : CII·Gang Chen, Leisha A Emens
Nov 3, 2011·Clinical & Developmental Immunology·Francesco DituriSalvatore Antonaci
Aug 30, 2011·Expert Opinion on Therapeutic Targets·Amal HasanSaid Dermime
Dec 21, 2012·Expert Review of Anticancer Therapy·Leisha A Emens
Jan 23, 2016·Biomaterials·C G Da SilvaLuis J Cruz
Jan 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Stéphane ChampiatJean-Charles Soria
Apr 5, 2012·International Journal of Cancer. Journal International Du Cancer·Vibeke Anett IngebrigtsenOystein Fodstad
Apr 9, 2014·Biochimica Et Biophysica Acta·Xiaohong Wang, Shulin Li
Jan 20, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yu FujitaTakahiro Ochiya
Jan 9, 2014·Hematology/oncology and Stem Cell Therapy·Sehar Afreen, Said Dermime
Jun 27, 2014·Frontiers in Oncology·Andrew NguyenYonghong Wan
Oct 26, 2016·Journal for Immunotherapy of Cancer·Lauren Van Der KraakMichael T Lotze
Oct 21, 2016·Gene Therapy·S K Jones, O M Merkel
Jul 30, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Flavia FontanaHélder A Santos
Jul 27, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Erin D LucasBeth A Jirón Tamburini
Jan 9, 2019·Journal of Cancer Research and Clinical Oncology·Marco GalloUNKNOWN NIKE Group
Nov 11, 2017·British Journal of Cancer·Jessica S BrownJuanita Lopez
Sep 29, 2018·Current Protein & Peptide Science·Ran WeiYao Lin
May 10, 2020·International Journal of Cancer. Journal International Du Cancer·Daniele CaraccioloPierfrancesco Tassone
May 26, 2017·Biomedicines·Audrey H ChoiNanhai G Chen
Dec 11, 2019·Journal of Clinical Medicine·Barbara Seliger
Jul 4, 2012·Molecular Medicine Reports·Fan WangDongsheng Huang
Jun 15, 2017·International Journal of Cancer. Journal International Du Cancer·Sheema AlmozyanHazem Ghebeh

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
FACS
Assay
I
flow cytometry
confocal microscopy
nuclear translocation
transfection

Software Mentioned

GraphPad
GraphPadPrism4
Cell Quest Pro

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.